Universe Pharmaceuticals INC (NASDAQ:UPC) Short Interest Down 27.5% in August

Universe Pharmaceuticals INC (NASDAQ:UPC) was the target of a large drop in short interest in August. As of August 31st, there was short interest totaling 22,200 shares, a drop of 27.5% from the August 15th total of 30,600 shares. Currently, 9.3% of the shares of the stock are short sold. Based on an average daily volume of 67,700 shares, the days-to-cover ratio is presently 0.3 days. Based on an average daily volume of 67,700 shares, the days-to-cover ratio is presently 0.3 days. Currently, 9.3% of the shares of the stock are short sold.

Universe Pharmaceuticals Price Performance

UPC opened at $3.90 on Tuesday. The business has a 50 day moving average of $3.68. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.62 and a current ratio of 2.78. Universe Pharmaceuticals has a 1 year low of $2.51 and a 1 year high of $600.00.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen raised shares of Universe Pharmaceuticals from a “strong sell” rating to a “hold” rating in a research note on Saturday, May 24th.

About Universe Pharmaceuticals

Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.